Practical application of new technologies for melanoma diagnosis: Part II. Molecular approaches.

The criterion standard for diagnosing cutaneous melanoma continues to be histologic examination. However, classifying some melanocytic lesions by conventional microscopy can be problematic if they exhibit some architectural or morphologic characteristics of both nevus and melanoma. Moreover, histologic appearance does not always predict biologic behavior. There is therefore a need and opportunity to develop new technologies that can facilitate the histologic diagnosis of melanoma and potentially help distinguish lesions with a lesser or greater risk of metastasis. In part II of this 2-part continuing medical education article, we will review the molecular technologies currently available for facilitating melanoma diagnosis, including comparative genomic hybridization, fluorescence in situ hybridization, and epidermal genetic retrieval. Our goal is to provide the clinician with an up to date understanding of these molecular approaches so that they can be applied to their management of challenging melanocytic lesions.

[1]  K. Duffy,et al.  The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. , 2012, Journal of the American Academy of Dermatology.

[2]  M. Mihm,et al.  Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics , 2014, European Journal of Dermatology.

[3]  B. Bastian,et al.  Assessment of Copy Number Status of Chromosomes 6 and 11 by FISH Provides Independent Prognostic Information in Primary Melanoma , 2011, The American journal of surgical pathology.

[4]  D. Schadendorf,et al.  Somatic alterations in the melanoma genome: A high‐resolution array‐based comparative genomic hybridization study , 2010, Genes, chromosomes & cancer.

[5]  Xinmin Li,et al.  De novo congenital melanoma: analysis of 2 cases with array comparative genomic hybridization. , 2014, The American Journal of dermatopathology.

[6]  J. Guitart,et al.  A Highly Specific and Discriminatory FISH Assay for Distinguishing Between Benign and Malignant Melanocytic Neoplasms , 2012, The American journal of surgical pathology.

[7]  Yu Fang,et al.  Fluorescence in Situ Hybridization for Distinguishing Nevoid Melanomas From Mitotically Active Nevi , 2009, The American journal of surgical pathology.

[8]  S. Sait,et al.  Chromosome changes in metastatic human melanoma. , 1988, Cancer genetics and cytogenetics.

[9]  John Quackenbush,et al.  Melanoma mimic: a case of multiple pagetoid Spitz nevi. , 2012, Archives of dermatology.

[10]  H. S. Robin,et al.  Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin. , 2014, Journal of the American Academy of Dermatology.

[11]  H. Bangash,et al.  What's new in prognostication of melanoma in the dermatopathology laboratory? , 2013, Clinics in dermatology.

[12]  R. Corona,et al.  Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  E. Farmer,et al.  Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. , 1996, Human pathology.

[14]  S. Swetter,et al.  Fluorescence In Situ Hybridization Analysis of Atypical Melanocytic Proliferations and Melanoma in Young Patients , 2014, Pediatric dermatology.

[15]  S. Diaz‐Cano Paratumoral gene expression profiles: promising markers of malignancy in melanocytic lesions , 2011, The British journal of dermatology.

[16]  S. Lodha,et al.  Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting , 2008, Journal of cutaneous pathology.

[17]  U. Francke,et al.  Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. , 1988, Journal of the National Cancer Institute.

[18]  E. Nagore,et al.  Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma , 2012, Histopathology.

[19]  A. D. Thompson,et al.  Current applications of molecular genetic technologies to the diagnosis and treatment of cutaneous melanocytic neoplasms. , 2013, Clinics in laboratory medicine.

[20]  J. Guitart,et al.  Atypical Spitz Tumors With 6q23 Deletions: A Clinical, Histological, and Molecular Study , 2013, The American Journal of dermatopathology.

[21]  D. Bostwick,et al.  Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization , 2011, Melanoma research.

[22]  I. Yeh,et al.  Melanoma ex blue nevus: two cases resembling large plaque‐type blue nevus with subcutaneous cellular nodules , 2012, Journal of cutaneous pathology.

[23]  N. Kolaitis,et al.  Fluorescence In Situ Hybridization as an Ancillary Tool in the Diagnosis of Ambiguous Melanocytic Neoplasms: A Review of 804 Cases , 2014, The American journal of surgical pathology.

[24]  L. Cerroni,et al.  Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases , 2011, Modern Pathology.

[25]  Sean Davis,et al.  Chromothripsis and focal copy number alterations determine poor outcome in malignant melanoma. , 2013, Cancer research.

[26]  D. Pinkel,et al.  Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. , 1999, The Journal of investigative dermatology.

[27]  R. González-Cámpora,et al.  Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax‐embedded tissues and imprint‐cytology specimens , 2012, Clinical and experimental dermatology.

[28]  J. Guitart,et al.  Distinguishing Epithelioid Blue Nevus From Blue Nevus-like Cutaneous Melanoma Metastasis Using Fluorescence In Situ Hybridization , 2009, The American journal of surgical pathology.

[29]  R. Iyer,et al.  Copy Number Variations and Clinical Outcome in Atypical Spitz Tumors , 2011, American Journal of Surgical Pathology.

[30]  S. Jhanwar,et al.  Fluorescence In Situ Hybridization (FISH) Analysis of Melanocytic Nevi and Melanomas , 2012, International journal of surgical pathology.

[31]  A. Quattrone,et al.  Increased frequency of minimal homozygous deletions is associated with poor prognosis in primary malignant melanoma patients , 2014, Genes, chromosomes & cancer.

[32]  M. van de Rijn,et al.  High-Resolution Array-Based Comparative Genomic Hybridization for Distinguishing Paraffin-Embedded Spitz Nevi and Melanomas , 2004, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[33]  J. Guitart,et al.  Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma , 2009, Modern Pathology.

[34]  C. Garbe,et al.  Recurrent nodules in a periauricular plaque‐type blue nevus with fatal outcome , 2012, Journal of cutaneous pathology.

[35]  A. Rademaker,et al.  Copy number gains in 11q13 and 8q24 [corrected] are highly linked to prognosis in cutaneous malignant melanoma. , 2011, The Journal of molecular diagnostics : JMD.

[36]  D. Pinkel,et al.  Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. , 1998, Cancer research.

[37]  W. Kuo,et al.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.

[38]  R. Gasparini,et al.  FISH as an effective diagnostic tool for the management of challenging melanocytic lesions , 2011, Diagnostic pathology.

[39]  S. Fox,et al.  Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines , 2014, Pigment cell & melanoma research.

[40]  T. Mentzel,et al.  A Proposal for Improving Multicolor FISH Sensitivity in the Diagnosis of Malignant Melanoma Using New Combined Criteria , 2012, The American Journal of dermatopathology.

[41]  D. Pinkel,et al.  Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .

[42]  M. Tetzlaff,et al.  Ambiguous Melanocytic Tumors in a Tertiary Referral Center: The Contribution of Fluorescence In Situ Hybridization (FISH) to Conventional Histopathologic and Immunophenotypic Analyses , 2013, The American journal of surgical pathology.

[43]  C. Lewis,et al.  A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. , 1994, Journal of the American Academy of Dermatology.

[44]  P. Gerami,et al.  Update on fluorescence in situ hybridization in melanoma: state of the art. , 2011, Archives of pathology & laboratory medicine.

[45]  A. Theos,et al.  Mitotically active proliferative nodule arising in a giant congenital melanocytic nevus: a diagnostic pitfall. , 2013, The American Journal of dermatopathology.

[46]  G. Mann,et al.  Diagnosis of cutaneous melanocytic tumours by four‐colour fluorescence in situ hybridisation , 2009, Pathology.

[47]  P. Nowell,et al.  Cytogenetics of human malignant melanoma and premalignant lesions. , 1984, Cancer genetics and cytogenetics.

[48]  J. Fridlyand,et al.  Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.

[49]  R. Ádány,et al.  Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization , 2012, Melanoma research.

[50]  V. Sondak,et al.  Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  A. Marghoob,et al.  Integrating clinical/dermatoscopic findings and fluorescence in situ hybridization in diagnosing melanocytic neoplasms with less than definitive histopathologic features. , 2012, Journal of the American Academy of Dermatology.

[52]  J. Tschen,et al.  Intratumoral heterogeneity of chromosome 9 loss and CDKN2A (p16) protein expression in a morphologically challenging spitzoid melanoma. , 2013, The American Journal of dermatopathology.

[53]  D. Elder,et al.  Identification of high-risk patients among those diagnosed with thin cutaneous melanomas. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  E. Mardis,et al.  A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen , 2012, Clinical Cancer Research.

[55]  D. Polsky,et al.  Noninvasive genomic detection of melanoma , 2011, The British journal of dermatology.

[56]  S. Lyle,et al.  Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions. , 2012, Archives of pathology & laboratory medicine.

[57]  J. Guitart,et al.  Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes. , 2010, Archives of dermatology.

[58]  J. Grichnik Stratum corneum RNA levels are diagnostic for melanoma , 2011, The British journal of dermatology.

[59]  A. Enk,et al.  Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up , 2010, Modern Pathology.

[60]  L. Morrison,et al.  Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma , 2009, The American journal of surgical pathology.

[61]  M. Mihm,et al.  Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. , 1999, Human pathology.

[62]  A. Dar,et al.  Prognostic Impact of PHIP Copy Number in Melanoma: Linkage to Ulceration , 2013, The Journal of investigative dermatology.

[63]  Daniel Pinkel,et al.  Classifying melanocytic tumors based on DNA copy number changes. , 2003, The American journal of pathology.

[64]  T. Stricker,et al.  Nevus Versus Melanoma: to FISH, or Not to FISH , 2011, Advances in anatomic pathology.

[65]  J. Guitart,et al.  Enhanced Detection of Spitzoid Melanomas Using Fluorescence In Situ Hybridization With 9p21 as an Adjunctive Probe , 2012, The American journal of surgical pathology.

[66]  D. Elder,et al.  Risk Assessment for Atypical Spitzoid Melanocytic Neoplasms Using FISH to Identify Chromosomal Copy Number Aberrations , 2013, The American journal of surgical pathology.

[67]  B. Bastian,et al.  Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool , 2006, Dermatologic therapy.

[68]  C. Garbe,et al.  Proliferative activity, chromosomal aberrations, and tumor-specific mutations in the differential diagnosis between blue nevi and melanoma. , 2013, The American journal of pathology.

[69]  T. McCalmont Fillet of FISH , 2011, Journal of cutaneous pathology.

[70]  K. Duffy,et al.  The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management. , 2012, Journal of the American Academy of Dermatology.

[71]  N. Kolaitis,et al.  Use of Fluorescence In situ Hybridization (FISH) to Distinguish Intranodal Nevus From Metastatic Melanoma , 2010, The American journal of surgical pathology.

[72]  D. Pinkel,et al.  Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas. , 2002, The American journal of pathology.

[73]  Robert W Cook,et al.  Development of a Prognostic Genetic Signature to Predict the Metastatic Risk Associated with Cutaneous Melanoma , 2015, Clinical Cancer Research.

[74]  L. Mazzucchelli,et al.  Presence of cytogenetic abnormalities in Spitz naevi: a diagnostic challenge for fluorescence in‐situ hybridization analysis , 2012, Histopathology.

[75]  C. Garbe,et al.  Molecular genetic classification of difficult melanocytic tumors , 2013, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[76]  D. Elder,et al.  Outcomes of Atypical Spitz Tumors With Chromosomal Copy Number Aberrations and Conventional Melanomas in Children , 2013, The American journal of surgical pathology.

[77]  K. Nishioka,et al.  Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome. , 2005, Cancer genetics and cytogenetics.

[78]  T. Godfrey,et al.  Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. , 2000, Cancer research.